Layton AM - Search Results

1

A honey trap for the treatment of acne: manipulating the follicular microenvironment to control Propionibacterium acnes.

Eady EA, Layton AM, Cove JH. Eady EA, et al. Among authors: layton am. Biomed Res Int. 2013;2013:679680. doi: 10.1155/2013/679680. Epub 2013 May 14. Biomed Res Int. 2013. PMID: 23762853 Free PMC article.

2

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers.

Eady AE, Cove JH, Layton AM. Eady AE, et al. Among authors: layton am. Am J Clin Dermatol. 2003;4(12):813-31. doi: 10.2165/00128071-200304120-00002. Am J Clin Dermatol. 2003. PMID: 14640775 Review.

3

A distinct acne microbiome: fact or fiction?

Eady EA, Layton AM. Eady EA, et al. Among authors: layton am. J Invest Dermatol. 2013 Sep;133(9):2294-5. doi: 10.1038/jid.2013.259. Epub 2013 Jun 12. J Invest Dermatol. 2013. PMID: 23760080 Free article. No abstract available.

4

IL-17: a key player in the P. acnes inflammatory cascade?

Thiboutot DM, Layton AM, Anne Eady E. Thiboutot DM, et al. Among authors: layton am. J Invest Dermatol. 2014 Feb;134(2):307-310. doi: 10.1038/jid.2013.400. J Invest Dermatol. 2014. PMID: 24424453 Free article.

5

Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership.

Layton A, Eady EA, Peat M, Whitehouse H, Levell N, Ridd M, Cowdell F, Patel M, Andrews S, Oxnard C, Fenton M, Firkins L. Layton A, et al. BMJ Open. 2015 Jul 17;5(7):e008085. doi: 10.1136/bmjopen-2015-008085. BMJ Open. 2015. PMID: 26187120 Free PMC article.

6

Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris.

Layton AM. Layton AM. Dermatol Clin. 2016 Apr;34(2):147-57. doi: 10.1016/j.det.2015.11.008. Epub 2016 Jan 28. Dermatol Clin. 2016. PMID: 27015774 Review.

7

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.

Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Layton AM, et al. Am J Clin Dermatol. 2017 Apr;18(2):169-191. doi: 10.1007/s40257-016-0245-x. Am J Clin Dermatol. 2017. PMID: 28155090 Free PMC article. Review.

8

Prioritizing treatment outcomes: How people with acne vulgaris decide if their treatment is working.

Layton AM, Whitehouse H, Eady EA, Cowdell F, Warburton KL, Fenton M. Layton AM, et al. J Evid Based Med. 2017 Aug;10(3):163-170. doi: 10.1111/jebm.12249. Epub 2017 May 24. J Evid Based Med. 2017. PMID: 28444879

9

Identifying What to Measure in Acne Clinical Trials: First Steps towards Development of a Core Outcome Set.

Layton AM, Eady EA, Thiboutot DM, Tan J; Acne Core Outcomes Research Network (ACORN) Outcomes Identification Group. Layton AM, et al. J Invest Dermatol. 2017 Aug;137(8):1784-1786. doi: 10.1016/j.jid.2017.04.017. Epub 2017 Apr 27. J Invest Dermatol. 2017. PMID: 28457913 Free PMC article. No abstract available.

10

Stemming the tide of antimicrobial resistance: implications for management of acne vulgaris.

Santer M, Francis NA, Platt D, Eady EA, Layton AM. Santer M, et al. Among authors: layton am. Br J Gen Pract. 2018 Feb;68(667):64-65. doi: 10.3399/bjgp18X694457. Br J Gen Pract. 2018. PMID: 29371295 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page